Entera Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Entera Bio
ENTX Stock  USD 1.95  0.07  3.72%   
Entera Bio financial statements provide useful quarterly and yearly information to potential Entera Bio investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Entera Bio financial statements helps investors assess Entera Bio's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Entera Bio's valuation are summarized below:
Gross Profit
9 K
Market Capitalization
71.8 M
Enterprise Value Revenue
632.7129
Revenue
99 K
Earnings Share
(0.26)
We have found one hundred twenty available fundamental signals for Entera Bio, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to verify all of Entera Bio prevailing market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road. Market Cap is likely to drop to about 19 M in 2025. Enterprise Value is likely to drop to about 7.4 M in 2025

Entera Bio Total Revenue

15,295

Check Entera Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Entera Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 97.3 K, Interest Expense of 31.4 M or Selling General Administrative of 5.2 M, as well as many indicators such as Price To Sales Ratio of 79.86, Dividend Yield of 0.0 or PTB Ratio of 1.58. Entera financial statements analysis is a perfect complement when working with Entera Bio Valuation or Volatility modules.
  
Check out the analysis of Entera Bio Correlation against competitors.
For more information on how to buy Entera Stock please use our How to Invest in Entera Bio guide.

Entera Bio Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets13.9 M13.5 M9.7 M
Slightly volatile
Short and Long Term Debt Total333.4 K351 K4.3 M
Slightly volatile
Other Current Liabilities1.6 M1 M1.1 M
Slightly volatile
Total Current Liabilities932.8 K981.9 K2.2 M
Very volatile
Other Liabilities35 K36.8 K49 K
Slightly volatile
Property Plant And Equipment Net305.4 K561.2 K270.7 K
Slightly volatile
Accounts Payable71 K74.7 K258.6 K
Slightly volatile
Cash11.8 M12.7 M7.9 M
Slightly volatile
Non Current Assets Total631.1 K457.2 K776.5 K
Slightly volatile
Long Term Debt3.3 M3.5 M10.4 M
Slightly volatile
Cash And Short Term Investments12.3 M12.7 M8.2 M
Slightly volatile
Common Stock Shares Outstanding19.3 M33.4 M16.9 M
Slightly volatile
Liabilities And Stockholders Equity13.9 M13.5 M9.7 M
Slightly volatile
Non Current Liabilities Total246.2 K259.2 K14.5 M
Slightly volatile
Other Current Assets209 K273.7 K187 K
Slightly volatile
Other Stockholder Equity138.5 M131.9 M50.4 M
Slightly volatile
Total Liabilities1.2 M1.2 M16.7 M
Slightly volatile
Property Plant And Equipment Gross359.9 K561.2 K301.9 K
Slightly volatile
Short and Long Term Debt25.1 M43 M29.1 M
Slightly volatile
Total Current Assets13 M12.9 M8.9 M
Slightly volatile
Accumulated Other Comprehensive Income35.1 K36.9 K3.3 M
Very volatile
Short Term Debt114.6 K120.6 K11 M
Slightly volatile
Intangible Assets509.7 K544.5 K622.6 K
Slightly volatile
Property Plant Equipment337.8 K263.4 K265.8 K
Slightly volatile
Non Current Liabilities Other108.8 K58.5 K158.6 K
Slightly volatile
Net Working Capital12.9 M11.7 M11.2 M
Pretty Stable
Current Deferred Revenue36.8 K38.7 K243.8 K
Very volatile
Capital Surpluse61.9 M72.9 M55.9 M
Slightly volatile
Other Assets41.9 K44.1 K571.5 K
Slightly volatile
Long Term Debt Total97.6 K109.8 K119.7 K
Slightly volatile
Capital Lease Obligations242.2 K351 K299.9 K
Very volatile
Common Stock8559007.4 M
Slightly volatile

Entera Bio Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization97.3 K64.4 K68.6 K
Slightly volatile
Selling General Administrative5.2 M5.1 M3.8 M
Slightly volatile
Other Operating Expenses11 M10.2 M8.1 M
Slightly volatile
Research Development5.7 M5.1 M4.3 M
Slightly volatile
Total Operating Expenses10.9 M10.2 M8 M
Slightly volatile
Reconciled Depreciation84.1 K53.1 K73.4 K
Slightly volatile
Interest Income696.3 K854.5 K623.3 K
Slightly volatile

Entera Bio Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Sale Purchase Of Stock10.2 M14.7 M8.6 M
Slightly volatile
Stock Based Compensation2 M1.9 M1.4 M
Slightly volatile
Begin Period Cash Flow10.5 M14.2 M7 M
Slightly volatile
Depreciation97.3 K64.4 K68.6 K
Slightly volatile
Capital Expenditures14.5 K15.3 K43 K
Slightly volatile
Total Cash From Financing Activities9.8 M6.9 M7.5 M
Slightly volatile
End Period Cash Flow11.8 M12.7 M8 M
Slightly volatile
Issuance Of Capital Stock4.3 K4.5 K7.8 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio79.8614179.0905
Slightly volatile
Days Sales Outstanding349603482
Pretty Stable
Stock Based Compensation To Revenue15.8515.096.1677
Slightly volatile
Capex To Depreciation0.330.351.1019
Slightly volatile
EV To Sales42.3259.1843.742
Slightly volatile
Payables Turnover1.160.610.8985
Slightly volatile
Sales General And Administrative To Revenue51.1548.7118.7995
Slightly volatile
Research And Ddevelopement To Revenue41.2439.2823.8137
Slightly volatile
Capex To Revenue0.330.320.1825
Slightly volatile
Cash Per Share0.840.440.5417
Slightly volatile
Days Payables Outstanding5916222.3 K
Slightly volatile
Income Quality1.120.950.9585
Very volatile
Intangibles To Total Assets0.09810.06780.1293
Slightly volatile
Current Ratio9.759.295.0596
Slightly volatile
Receivables Turnover0.470.490.8536
Pretty Stable
Capex Per Share6.0E-47.0E-40.0036
Slightly volatile
Revenue Per Share0.00510.00530.0404
Slightly volatile
Interest Debt Per Share0.01470.01550.3987
Slightly volatile
Debt To Assets0.03620.03811.2768
Slightly volatile
Days Of Payables Outstanding5916222.3 K
Slightly volatile
Quick Ratio9.759.295.0695
Slightly volatile
Net Income Per E B T1.11.151.0212
Slightly volatile
Cash Ratio9.549.094.4448
Slightly volatile
Days Of Sales Outstanding349603482
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio1.111.151.0251
Slightly volatile
Fixed Asset Turnover1.551.111.7834
Slightly volatile
Debt Ratio0.03620.03811.2768
Slightly volatile
Price Sales Ratio79.8614179.0905
Slightly volatile
Asset Turnover0.01120.01170.0283
Slightly volatile
Gross Profit Margin0.220.24630.1755
Slightly volatile

Entera Bio Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap19 M20 M48.6 M
Slightly volatile
Enterprise Value7.4 M7.8 M45 M
Slightly volatile

Entera Fundamental Market Drivers

Cash And Short Term Investments11 M

Entera Upcoming Events

29th of March 2024
Upcoming Quarterly Report
View
3rd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
29th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Entera Bio Financial Statements

Entera Bio investors use historical fundamental indicators, such as Entera Bio's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Entera Bio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue38.7 K36.8 K
Total Revenue16.1 K15.3 K
Cost Of Revenue64.4 K116 K
Stock Based Compensation To Revenue 15.09  15.85 
Sales General And Administrative To Revenue 48.71  51.15 
Research And Ddevelopement To Revenue 39.28  41.24 
Capex To Revenue 0.32  0.33 
Revenue Per Share 0.01  0.01 
Ebit Per Revenue(111.71)(106.13)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
CRMSalesforce
CRMSalesforce

Additional Tools for Entera Stock Analysis

When running Entera Bio's price analysis, check to measure Entera Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entera Bio is operating at the current time. Most of Entera Bio's value examination focuses on studying past and present price action to predict the probability of Entera Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entera Bio's price. Additionally, you may evaluate how the addition of Entera Bio to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY